Non-hormonal treatments for menopausal symptoms

@article{Hickey2017NonhormonalTF,
  title={Non-hormonal treatments for menopausal symptoms},
  author={Martha Hickey and Rebecca A. Szabo and Myra S. Hunter},
  journal={British Medical Journal},
  year={2017},
  volume={359}
}
#### What you need to know Menopause is a normal event, and most women do not seek medical intervention. Of those who do, some will require only information and advice, but around 25% have problematic symptoms that may need treatment. Vasomotor symptoms are the main reason that women seek treatment. Hormone replacement therapy is effective for vasomotor symptoms, but for some it is unsuitable (due to preference or contraindications) and non-hormonal treatments can be considered. This update… Expand
Managing menopausal symptoms after cancer
TLDR
Management of menopausal symptoms after cancer may be challenging and should include information about induced menopause and possible symptoms as well as available treatments, which requires a holistic and multidisciplinary approach with individualized care. Expand
Nonpharmacological therapies for the management of menopausal vasomotor symptoms in breast cancer survivors
TLDR
Evidence for nonpharmacological interventions supports cognitive behavioural therapy and hypnosis in the management of vasomotor symptoms in breast cancer survivors. Expand
The Management of Menopausal Symptoms in Women Following Breast Cancer: An Overview
TLDR
There is a dearth of good quality evidence on the safest and most effective treatment options available for high-risk women with menopausal symptoms following breast cancer, and this article aims to summarize the current available treatments. Expand
Cognitive behavioral therapy for menopausal symptoms
  • M. Hunter
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2020
TLDR
CBT is a brief therapy that is acceptable to women and effectively reduces the impact of VMS, improves sleep and has benefits to quality of life, and telephone CBT has been shown to be an effective treatment for insomnia. Expand
Protocol for development of a core outcome set for menopausal symptoms (COMMA)
TLDR
A Core Outcome Set for Menopausal Symptoms will better enable women and clinicians to select effective treatments, improve the quality of trial reporting, reduce research wastage, and improve care for women with troublesome menopausal symptoms. Expand
Managing vasomotor symptoms effectively without hormones
TLDR
The evidence for non-hormonal treatments for vasomotor symptoms, including pharmacological and non-pharmacological approaches, are reviewed, and a clinical algorithm for managing symptomatic women is provided. Expand
Healthcare Utilization and Prevalence of Symptoms in Women with Menopause: A Real-World Analysis
TLDR
Symptomatic peri- and post-menopausal women, and particularly those under 52 years, were more likely to have a higher prevalence of comorbid conditions such as depression, anxiety, osteoporosis and insomnia in the year following index. Expand
Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study
TLDR
The need for MHT users and their clinicians to re-evaluate continued MHT use on an ongoing basis is reinforced, as ever-use of non-MHT menopausal therapies was associated with M HT use for <5 years but not with longer-term use. Expand
Hormone replacement therapy for women previously treated for endometrial cancer.
TLDR
A large number of women diagnosed with endometrial cancer have early-stage disease, leading to a good prognosis after hysterectomy and removal of the ovaries, and there is a need for information about the risk and benefits of HRT, enabling women to make an informed decision, weighing the advantages and disadvantages of using HRT for their individual circumstances. Expand
Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors
To determine the nature and severity of vasomotor symptoms, sexual problems, mood and sleep disturbance in community-dwelling breast cancer patients, whether and where they received treatment forExpand
...
1
2
3
...

References

SHOWING 1-10 OF 98 REFERENCES
Exercise for vasomotor menopausal symptoms.
TLDR
No evidence is found from randomised controlled trials on whether exercise is an effective treatment relative to other interventions or no intervention in reducing hot flushes and or night sweats in symptomatic women. Expand
EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms.
TLDR
There is insufficient or conflicting evidence to suggest that exercise, supplements or a diet rich in phytoestrogens are effective for vasomotor menopausal symptoms. Expand
Relaxation for perimenopausal and postmenopausal symptoms.
TLDR
Evidence is insufficient to show the effectiveness of relaxation techniques as treatment for menopausal vasomotor symptoms, or to determine whether this treatment is more effective than no treatment, placebo, acupuncture, superficial needle insertion or paced respiration. Expand
A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients
TLDR
It is illustrated that certain non-hormonal treatments, including selective serotonin reuptake inhibitors, gabapentin/pregabalin, and Cimicifuga racemosa extracts, show a positive risk-benefit ratio. Expand
Management of menopausal symptoms in patients with breast cancer: an evidence-based approach.
TLDR
It is proposed that the management of menopausal symptoms in patients with a history of cancer requires a patient-centred, but multidisciplinary, approach. Expand
Consensus statement for non-hormonal-based treatments for menopausal symptoms
  • J. Woyka
  • Medicine
  • Post reproductive health
  • 2017
Since the June 2014 consensus statement published in Post Reproductive Health we have had definitive guidelines on menopause treatment from the National Institute for Clinical Excellence in NovemberExpand
Revisiting the Duration of Vasomotor Symptoms of Menopause: A Meta-Analysis
TLDR
The findings suggest a median symptom duration of about 4 years among symptomatic women and a longer symptom duration may affect treatment decisions and clinical guidelines. Expand
Black cohosh (Cimicifuga spp.) for menopausal symptoms.
TLDR
There is currently insufficient evidence to support the use of black cohosh for treating menopausal symptoms in perimenopausal and postmenopausal women, and evidence on the safety ofblack cohosh was inconclusive. Expand
Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society
TLDR
Clinicians need to be well informed about the level of evidence available for the wide array of nonhormonal management options currently available to midlife women to help prevent underuse of effective therapies or use of inappropriate or ineffective therapies. Expand
Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society
TLDR
The Menopause Decision-Support Algorithm and companion MenoPro iPhone/iPad app are designed to help clinicians decide which patients are candidates for pharmacologic treatment of menopausal symptoms, understand what the treatment options are, and gain experience deciding among the options. Expand
...
1
2
3
4
5
...